# Attain Stability™ Quad Clinical Study

Study · id `cardio:ct-nct03099655` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03099655](<https://clinicaltrials.gov/study/NCT03099655>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03099655

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 471 participants.

## Technical summary

Registry record NCT03099655. Allocation not applicable; no masking; primary purpose treatment. Start 2017-07-07 (actual); primary completion 2018-08-02 (actual). Results posted on 2020-01-09.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 471 participants (enrolled count; ClinicalTrials.gov record NCT03099655, source copy `cardio:ctgov-nct03099655-2020-01-09`, retrieved 2026-10-26)
- Started: 2017-07-07 (actual) (ClinicalTrials.gov record NCT03099655, source copy `cardio:ctgov-nct03099655-2020-01-09`, retrieved 2026-10-26)
- Primary completion: 2018-08-02 (actual) (ClinicalTrials.gov record NCT03099655, source copy `cardio:ctgov-nct03099655-2020-01-09`, retrieved 2026-10-26)
- Completion: 2019-05-31 (actual) (ClinicalTrials.gov record NCT03099655, source copy `cardio:ctgov-nct03099655-2020-01-09`, retrieved 2026-10-26)
- Results first posted: 2020-01-09 (ClinicalTrials.gov record NCT03099655, source copy `cardio:ctgov-nct03099655-2020-01-09`, retrieved 2026-10-26)
- Countries: United States; Canada; Germany; Hong Kong SAR China; Italy; Malaysia; Netherlands; Norway; Spain; Sweden (ClinicalTrials.gov record NCT03099655, source copy `cardio:ctgov-nct03099655-2020-01-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03099655-2020-01-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Attain Stability™ Quad Clinical Study
- Condition: Heart Failure
- Intervention (Device): Attain Stability Quad Left Ventricular Pacing Lead
- Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Medtronic Cardiac Rhythm and Heart Failure (`cardio:org-medtronic-cardiac-rhythm-and-heart-failure`)

## Provenance

Content hash: bc31e6032778e2e75c5b74a6040d0d183d8be33b1f14f5ea087b736a0400a1ef
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
